Back
UroGen Pharma Stock Price Chart
Sponsored
URGN
Sponsored
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Buy
53
URGN
UroGen Pharma
Last Price:
14.08
Seasonality Move:
-7.76%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing selling pressure, which indicates risk of future bearish movement.
UroGen Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.14 | Sell |
20-day SMA: | 13.99 | Buy |
50-day SMA: | 15.69 | Sell |
200-day SMA: | 15.19 | Sell |
8-day EMA: | 14.13 | Sell |
20-day EMA: | 14.33 | Sell |
50-day EMA: | 14.99 | Sell |
200-day EMA: | 14.49 | Sell |
UroGen Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 45.33 | Sell |
Chaikin Money Flow: | -133557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.44 - 15.02) | Sell |
Bollinger Bands (100): | (13.85 - 17.25) | Sell |
UroGen Pharma Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for UroGen Pharma Stock
Is UroGen Pharma Stock a Buy?
- UroGen Pharma share price is 14.04 while URGN 8-day simple moving average is 14.14, which is a Sell signal.
- The stock price of URGN is 14.04 while UroGen Pharma 20-day SMA is 13.99, which makes it a Buy.
- UroGen Pharma 50-day simple moving average is 15.69 while URGN share price is 14.04, making it a Sell technically.
- URGN stock price is 14.04 and UroGen Pharma 200-day simple moving average is 15.19, creating a Sell signal.
URGN Technical Analysis vs Fundamental Analysis
Buy
53
UroGen Pharma (URGN)
is a Buy
Is UroGen Pharma a Buy or a Sell?
-
UroGen Pharma stock is rated a Buy
The current UroGen Pharma [URGN] share price is $14.04. The Score for URGN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
UroGen Pharma Stock Info
Market Cap:
479.07M
Price in USD:
14.04
Share Volume:
198.39K
UroGen Pharma 52-Week Range
52-Week High:
24.13
52-Week Low:
8.69
Buy
53
UroGen Pharma (URGN)
is a Buy
UroGen Pharma Share Price Forecast
-
What is the UroGen Pharma stock price today?
The UroGen Pharma stock price is 14.04 USD today. -
Will URGN stock go up or go down?
UroGen Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is UroGen Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, UroGen Pharma is not overvalued.
Is UroGen Pharma Stock a Buy?
- UroGen Pharma share price is 14.04 while URGN 8-day exponential moving average is 14.13, which is a Sell signal.
- The stock price of URGN is 14.04 while UroGen Pharma 20-day EMA is 14.33, which makes it a Sell.
- UroGen Pharma 50-day exponential moving average is 14.99 while URGN share price is 14.04, making it a Sell technically.
- URGN stock price is 14.04 and UroGen Pharma 200-day simple moving average is 14.49, creating a Sell signal.
Fundamental Analysis of UroGen Pharma
Is UroGen Pharma a good investment?
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.06 per share, and an increase next year of $1.71 per share.
Technical Analysis of UroGen Pharma
Should I short UroGen Pharma stock?
- URGN Moving Average Covergence Divergence (MACD) indicator is -0.33, suggesting UroGen Pharma is a Sell
- UroGen Pharma Relative Strength Index (RSI) is 45.33, which suggest UroGen Pharma is oversold
- The Bollinger Bands (25) for UroGen Pharma is (13.44 - 15.02), which suggest UroGen Pharma is a Sell
- The Bollinger Bands (100) for UroGen Pharma is (13.85 - 17.25), which suggest UroGen Pharma is a Sell
* UroGen Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.